APA (7th ed.) Citation

Khushman, M., Patel, G. K., Maharjan, A. S., McMillin, G. A., Nelson, C., Hosein, P., & Singh, A. P. (2021). The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens. The Pharmacogenomics Journal, 21(3), 308. https://doi.org/10.1038/s41397-021-00210-2

Chicago Style (17th ed.) Citation

Khushman, Moh’d, Girijesh Kumar Patel, Anu Singh Maharjan, Gwendolyn A. McMillin, Cindy Nelson, Peter Hosein, and Ajay P. Singh. "The Prevalence and Clinical Relevance of 2R/2R TYMS Genotype in Patients with Gastrointestinal Malignancies Treated with Fluoropyrimidine-based Chemotherapy Regimens." The Pharmacogenomics Journal 21, no. 3 (2021): 308. https://doi.org/10.1038/s41397-021-00210-2.

MLA (9th ed.) Citation

Khushman, Moh’d, et al. "The Prevalence and Clinical Relevance of 2R/2R TYMS Genotype in Patients with Gastrointestinal Malignancies Treated with Fluoropyrimidine-based Chemotherapy Regimens." The Pharmacogenomics Journal, vol. 21, no. 3, 2021, p. 308, https://doi.org/10.1038/s41397-021-00210-2.